Evidence map›Paper›PMID 35508574›Full record

ArticleCellular and molecular life sciences : CMLS2022

The mechanism of activation of MEK1 by B-Raf and KSR1.

Ryan C Maloney, Mingzhen Zhang, Yonglan Liu, Hyunbum Jang, Ruth Nussinov

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. ERK autoinhibition mechanism informs a drug combination strategy.Protein science : a publication of the Protein Society · 2026
    Article
  2. Article
  3. Article
  4. Allostery in Biomolecular Condensates.Journal of molecular biology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Targeted therapy of papillary craniopharyngioma.Medical oncology (Northwood, London, England) · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Imaging the Raf-MEK-ERK Signaling Cascade in Living Cells.International journal of molecular sciences · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Strategy toward Kinase-Selective Drug Discovery.Journal of chemical theory and computation · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ryan C MaloneyCancer Innovation Laboratory, National Cancer Institute, Frederick, MD, 21702, USA.
Mingzhen ZhangComputational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Yonglan LiuCancer Innovation Laboratory, National Cancer Institute, Frederick, MD, 21702, USA.
Hyunbum JangComputational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Ruth NussinovComputational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA. NussinoR@mail.nih.gov.ORCID http://orcid.org/0000-0002-8115-6415
Frederick National Laboratory for Cancer Research · USNational Cancer Institute · USTel Aviv University · IL

Funding

Protein Structure, Stability, and Amyloid FormationZIABC010440 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSINOV, RUTH · 2009 to 2025
$11.8M
Biomolecular Recognition and Binding MechanismsZIABC010441 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSINOV, RUTH · 2009 to 2025
$9.4M
NCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003I
6 · The paper itself

Abstract

MEK1 interactions with B-Raf and KSR1 are key steps in Ras/Raf/MEK/ERK signaling. Despite this, vital mechanistic details of how these execute signal transduction are still enigmatic. Among these is why, despite B-Raf and KSR1 kinase domains similarity, the B-Raf/MEK1 and KSR1/MEK1 complexes have distinct contributions to MEK1 activation, and broadly, what is KSR1's role. Our molecular dynamics simulations clarify these still unresolved ambiguities. Our results reveal that the proline-rich (P-rich) loop of MEK1 plays a decisive role in MEK1 activation loop (A-loop) phosphorylation. In the inactive B-Raf/MEK1 heterodimer, the collapsed A-loop of B-Raf interacts with the P-rich loop and A-loop of MEK1, minimizing MEK1 A-loop fluctuation and preventing it from phosphorylation. In the active B-Raf/MEK1 heterodimer, the P-rich loop moves in concert with the A-loop of B-Raf as it extends. This reduces the number of residues interacting with MEK1 A-loop, allowing increased A-loop fluctuation, and bringing Ser222 closer to ATP for phosphorylation. B-Raf αG-helix Arg662 promotes MEK1 activation by orienting Ser218 towards ATP. In KSR1/MEK1, the KSR1 αG-helix has Ala826 in place of B-Raf Arg662. This difference results in much fewer interactions between KSR1 αG-helix and MEK1 A-loop, thus a more flexible A-loop. We postulate that if KSR1 were to adopt an active configuration with an extended A-loop as seen in other protein kinases, then the MEK1 P-rich loop would extend in a similar manner, as seen in the active B-Raf/MEK1 heterodimer. This would result in highly flexible MEK1 A-loop, and KSR1 functioning as an active, B-Raf-like, kinase.

Indexed as

Protein KinasesProto-Oncogene Proteins B-rafAdenosine TriphosphateMAP Kinase Kinase 1PhosphorylationProto-Oncogene Proteins c-rafSignal TransductionAdenosine TriphosphateMAP Kinase Kinase 1Protein KinasesProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-rafAssembliesAutoinhibitionCancerERKKSRMAPKMD simulations

Identifiers

PMID35508574
PMCPMC9068654
OpenAlexW4229006461

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.